Study S001298

Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03889496
Acronym: GLP1-ex-vivo
Study type: INTERVENTIONAL
Masking: NONE
Status: TERMINATED
Enrollment: 12
Start: 2015-11-16
Primary completion: 2021-06-14
Lead sponsor: Radboud University Medical Center
Conditions: Diabetes Mellitus
Interventions: RADIATION:indium-111-exendin SPECT/CT
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Correlation between the tracer uptake (counts) and beta cell mass (mg) [4 years]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0014201	Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas. Jansen TJP, EJNMMI research	2024	Other trial	PMID 39405026 DOI	cites ClinicalTrials.gov:NCT03889496; registry reference DERIVED:39405026